# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030757
Filing Date
2024-08-08
Accepted
2024-08-08 16:06:29
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1361764
2 |  | ex31-1.htm | EX-31.1 | 18476
3 |  | ex31-2.htm | EX-31.2 | 18598
4 |  | ex32-1.htm | EX-32.1 | 7287
5 |  | ex32-2.htm | EX-32.2 | 7326
| Complete submission text file | 0001493152-24-030757.txt |  | 6783737

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | lixt-20240630.xsd | EX-101.SCH | 46482
7 | XBRL CALCULATION FILE | lixt-20240630_cal.xml | EX-101.CAL | 32244
8 | XBRL DEFINITION FILE | lixt-20240630_def.xml | EX-101.DEF | 241903
9 | XBRL LABEL FILE | lixt-20240630_lab.xml | EX-101.LAB | 405865
10 | XBRL PRESENTATION FILE | lixt-20240630_pre.xml | EX-101.PRE | 327060
61 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1139126

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 241188225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)